These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32595039)

  • 1. Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK.
    Wu P; Zhao J; Guo Y; Yu Y; Wu X; Xiao H
    Biochem Biophys Res Commun; 2020 Aug; 529(3):834-838. PubMed ID: 32595039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
    Huang Q; Wang T; Yang L; Wang HY
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients.
    Mueller M; Castro RE; Thorell A; Marschall HU; Auer N; Herac M; Rodrigues CMP; Trauner M
    Liver Int; 2018 Mar; 38(3):523-531. PubMed ID: 28853202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of nonalcoholic fatty liver disease: role of AMPK.
    Smith BK; Marcinko K; Desjardins EM; Lally JS; Ford RJ; Steinberg GR
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E730-E740. PubMed ID: 27577854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease.
    Gheibi S; Gouvarchin Ghaleh HE; Motlagh BM; Azarbayjani AF; Zarei L
    Biomed Pharmacother; 2019 Jul; 115():108938. PubMed ID: 31071511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.
    Ye HL; Zhang JW; Chen XZ; Wu PB; Chen L; Zhang G
    Life Sci; 2020 Feb; 242():117175. PubMed ID: 31843528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway.
    Afshari H; Noori S; Zarghi A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3135-3148. PubMed ID: 37209153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
    Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
    Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway.
    Pant R; Sharma N; Kabeer SW; Sharma S; Tikoo K
    Biol Trace Elem Res; 2023 Mar; 201(3):1344-1357. PubMed ID: 35499800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR-mediated autophagy in mice.
    Ding Y; Chen Y; Hu K; Yang Q; Li Y; Huang M
    J Cell Biochem; 2023 Jul; 124(7):1012-1022. PubMed ID: 37269482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
    Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
    Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.
    Namisaki T; Noguchi R; Moriya K; Kitade M; Aihara Y; Douhara A; Nishimura N; Takeda K; Okura Y; Kawaratani H; Takaya H; Seki K; Yoshiji H
    J Gastroenterol; 2016 Feb; 51(2):162-72. PubMed ID: 26190501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
    Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway.
    Liang Y; Zhang Z; Tu J; Wang Z; Gao X; Deng K; El-Samahy MA; You P; Fan Y; Wang F
    J Agric Food Chem; 2021 Jul; 69(29):8257-8267. PubMed ID: 34281337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice.
    Zhang M; Xie ZF; Zhang RT; Chen DK; Gu M; Cui SC; Zhang YM; Zhang XW; Yu YY; Li J; Nan FJ; Li JY
    Acta Pharmacol Sin; 2018 Oct; 39(10):1622-1632. PubMed ID: 29795358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suppressive effects of Britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS.
    Cui YQ; Liu YJ; Zhang F
    Biochem Biophys Res Commun; 2018 Mar; 497(3):916-923. PubMed ID: 29288670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [UDCA in the treatment of nonalcoholic fatty liver disease].
    Grigor'eva IN
    Eksp Klin Gastroenterol; 2011; (11):79-85. PubMed ID: 22629725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.